• About
• Latest Posts
• Latest Blog Posts
• Boards Posted On
• Boards Moderating

skipper1072

Send Private Message

Follow Member

Block Messages

Ignore This User

Displaying 301-350 of 400 result(s).

Board Name	Posts By skipper1072	Post Created
GNBTQ Generex Biotechnology Corp.	Great questions. Even though he isn	04/08/2020 11:59:04 AM
GNBTQ Generex Biotechnology Corp.	We're dealing with huge bureaucraci (2)	04/07/2020 9:43:32 AM
GNBTQ Generex Biotechnology Corp.	I haven't been happy with Epivax fr (1)	04/01/2020 4:50:01 PM
GNBTQ Generex Biotechnology Corp.	Source tells me this is the lobby o (1)	03/26/2020 1:49:35 PM
GNBTQ Generex Biotechnology Corp.	Skipper is ready for any day, 1200	03/22/2020 12:18:12 PM
GNBTQ Generex Biotechnology Corp.	Ye of little faith. I'm hoping for	03/20/2020 3:44:41 PM
GNBTQ Generex Biotechnology Corp.	Vaccine/test revenues will show nex (1)	03/20/2020 3:17:35 PM
GNBTQ Generex Biotechnology Corp.	docj - you summed it up nicely. We (2)	03/19/2020 10:06:27 PM
GNBTQ Generex Biotechnology Corp.	We're in for stunningly large numbe	03/19/2020 4:11:35 PM
GNBTQ Generex Biotechnology Corp.	As usual, RJS focused on the real n (1)	03/19/2020 10:39:56 AM
GNBTQ Generex Biotechnology Corp.	Wonderful podcast performance by Jo	03/18/2020 9:34:04 AM
GNBTQ Generex Biotechnology Corp.	I'm still buying, accumulating. The (6)	03/11/2020 1:59:46 PM
GNBTQ Generex Biotechnology Corp.	EVH's explanations are too scientif (1)	03/10/2020 4:12:11 PM
GNBTQ Generex Biotechnology Corp.	1500 tests conducted in US so far.	03/06/2020 8:58:57 PM
GNBTQ Generex Biotechnology Corp.	Research doesn't generate immediate	03/04/2020 7:40:43 PM
GNBTQ Generex Biotechnology Corp.	It's hard to do the research withou	03/04/2020 6:57:11 PM
GNBTQ Generex Biotechnology Corp.	Good to know. Joe should bring DeGr (1)	03/04/2020 2:14:59 PM
GNBTQ Generex Biotechnology Corp.	Article from All Aboard: "The advan	03/04/2020 1:52:13 PM
GNBTQ Generex Biotechnology Corp.	This is the first I've heard this:	03/04/2020 1:44:52 PM
GNBTQ Generex Biotechnology Corp.	I see this as a wonderful buying op (3)	03/04/2020 1:00:58 PM
GNBTQ Generex Biotechnology Corp.	Unless EpiVax accelerates that proc (1)	03/04/2020 10:07:58 AM
GNBTQ Generex Biotechnology Corp.	No. I received that from Joe. (2)	03/02/2020 10:00:37 AM
GNBTQ Generex Biotechnology Corp.	Joe and team are flying to China to (3)	03/02/2020 2:47:58 AM
GNBTQ Generex Biotechnology Corp.	Is our vaccine RNA-based?	02/29/2020 8:10:03 PM
GNBTQ Generex Biotechnology Corp.	Big money will be in our testing ki	02/28/2020 9:58:45 AM
GNBTQ Generex Biotechnology Corp.	Nice post, Doc. You should work for (1)	02/27/2020 8:12:23 PM
GNBTQ Generex Biotechnology Corp.	It will have to push the timeline f	02/27/2020 6:24:09 PM
GNBTQ Generex Biotechnology Corp.	I keep in mind the fact that years	02/27/2020 9:55:59 AM
GNBTQ Generex Biotechnology Corp.	After 45 minuets with Fidelity, her	02/27/2020 9:18:53 AM
GNBTQ Generex Biotechnology Corp.	Thank you. You saved me another cal	02/26/2020 9:46:19 PM
GNBTQ Generex Biotechnology Corp.	Paul - I'll let you know what my Fi (1)	02/26/2020 9:22:18 PM
GNBTQ Generex Biotechnology Corp.	TC - likewise for me since I bought	02/26/2020 10:28:39 AM
GNBTQ Generex Biotechnology Corp.	1100	02/19/2020 8:02:08 AM
GNBTQ Generex Biotechnology Corp.	I'm not a fan of Dr. Craig Eagle. H (1)	01/30/2020 9:59:21 AM
GNBTQ Generex Biotechnology Corp.	On the positive side, the reduction	12/23/2019 7:48:03 PM
GNBTQ Generex Biotechnology Corp.	10Q - I didn't see one positive in (2)	12/16/2019 8:12:25 PM
GNBTQ Generex Biotechnology Corp.	Uplisting to NAZ when we file S1 an (1)	11/29/2019 10:57:24 AM
GNBTQ Generex Biotechnology Corp.	S1 filing = $40 million	11/29/2019 10:09:04 AM
GNBTQ Generex Biotechnology Corp.	Now is the time for a class action	11/26/2019 3:35:57 PM
GNBTQ Generex Biotechnology Corp.	Docj - I've been around a long time	11/24/2019 10:52:21 AM
GNBTQ Generex Biotechnology Corp.	#8506, then #8530 would infer that.	11/14/2019 8:42:39 AM
GNBTQ Generex Biotechnology Corp.	Respectfully docj, there are no win	11/14/2019 8:35:23 AM
GNBTQ Generex Biotechnology Corp.	I'm impressed with the pps stabilit (1)	11/12/2019 12:11:17 PM
GNBTQ Generex Biotechnology Corp.	Current liabilities dwarf current a (1)	11/12/2019 9:46:54 AM
GNBTQ Generex Biotechnology Corp.	Is Annual Meeting still on for tomo	10/24/2019 10:21:30 AM
GNBTQ Generex Biotechnology Corp.	Are we sure it is a NASDAQ absolute	10/17/2019 8:26:16 PM
GNBTQ Generex Biotechnology Corp.	The proof is in the stock price and	08/12/2019 10:04:42 AM
GNBTQ Generex Biotechnology Corp.	Very, very strange.	08/12/2019 8:15:21 AM
GNBTQ Generex Biotechnology Corp.	Be careful - you're day-trading in	07/27/2019 11:00:12 AM
GNBTQ Generex Biotechnology Corp.	Notes from today's CC: GNBT 7/25/19 (1)	07/25/2019 5:56:10 PM

• Next >

57287385727171572137757150945711000571000757099535708990570880857081655706546569981256988415696198569387056938445693637569360056935965693504569322156908895690532568996856887545688302568823856874755687397568712056871145686353567915656588165626685562067556053955605330560346756011195591882559186755898595589561557332755680135507708550743454942335492948

Recent Articles

• Investors Urged to Act on Evolv Technologies Securities Violations
• Important Updates for Shareholders of Xiao-I Corporation
• Key Steps for Xerox Holdings Corp Shareholders Regarding Class Action
• PACS Group, Inc. Shareholders Face Class Action Lawsuit Risks
• Key Information for Humacyte, Inc. Investors in Class Action
• Deadline Approaches for Chipotle Lawsuit Shareholders – Act Now
• Lilium N.V. Faces Class Action Lawsuit Over Fundraising Claims
• Important Update for Hasbro, Inc. Investors on Pending Class Action
• Zoom Video's Q3 Results Show Stable Growth, But Challenges Ahead
• Inter-American Development Bank Launches $10 Million Debt Notes
• FIVE Holdings Reports Strong Q3 Growth, Revenue Soars
• Frontline Ltd Navigates Market Challenges with Resilience
• CaliberCos Faces Challenges as Stock Hits New Low of $0.45
• Antitrust Trial Against Google to Proceed Without Delays
• Bitcoin Faces Critical Support Test as Price Drops Towards $90K
• CryptoQuant CEO Shares Insights on Bitcoin's Market Shifts
• Expert Insights on Abercrombie & Fitch's Options Trends
• Analyzing Workday's Options Trading Landscape and Insights
• Understanding Blackstone's Strategic Options Trading Moves
• VinFast Achieves Impressive Q3 Sales Growth and Vehicle Delivery Success
• Shineco Inc's Stock Struggles: Analyzing Recent Developments
• Banzai International Faces Challenges as BNZI Stock Hits Low
• StealthGas Facing Challenges Yet Shows Strong Financial Potential
• Seaboard Corp Faces Challenges with Recent Stock Decline
• CBOE Holdings Achieves New Heights with $216.97 Stock Price
• Gladstone Land Achieves New Milestone with Stock Surge
• Commvault's Stock Breaks Records: A Closer Look at CVLT
• Anheuser-Busch InBev Initiates Bond Buyback Strategy in EUR/GBP
• Gladstone Commercial Reaches Milestone with 52-Week High
• Global Companies Adjust Currency Strategies Amid Trade Uncertainty
• Traditional Pay TV Faces Challenges as Streaming Dominates
• Trading Opportunities Rise as Israeli Market Volatility Peaks
• UBS Reassesses U.S. Airline Stocks with Buy Ratings
• TOYO Co. Secures Major Contract Boosting Share Prices
• Impact of Canopy USA’s Acquisition on Acreage Shareholders
• Class Action Lawsuit Deadlines Approaching for Investors
• Insights on Options Activity for Intuitive Machines Stock
• Smart Investors Maneuver in Spotify Options Market Insights
• Recent Trends in Trump Media's Options Activity
• Could Elon Musk Make a Bold Move and Buy MSNBC?
• Wolfspeed Investors Sued Amid Disappointing Financial Results
• Maxeon Solar Technologies: Strategic Shift to U.S. Market
• Legal Action Initiated Against Match Group Amid Investor Concern
• Wohl & Fruchter Investigating TKO Group Holdings Directors
• Why Exact Sciences Corp. Stock Sees Gains After CMS Decision
• Amazon Leads in Holiday Spending Amidst Retail Competition
• Automakers Face Stock Decline as Tariff Threat Looms
• American Woodmark Faces Challenges Amid Housing Market Decline
• Understanding Class Actions: Key Insights for Investors
• Insights into Dollar General's Recent Unusual Options Activity